Back to VA VANGUARD CAPITAL MANAGEMENT LLC
TRVI2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in TREVI THERAPEUTICS INC
Yes. Vanguard Capital Management holds 5,530,675 shares of TRVI (Trevi Therapeutics), worth $103.1M, as of its Q2 2026 13F filing. It increased the position by 552,108 shares (+11.1%) from Q1 2026. Vanguard Capital Management has held TRVI in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$103.1M
Current Shares
5.5M
Total Value Change
+$43.8M
Total Shares Change
+552,108
Quarter-by-Quarter History
Other major holders of TRVI: FMR LLC, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP